Cargando…
Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy
Background: Presently, colistin is commercially available in two different forms, namely, colistin sulfate and its sulphomethylated derivative, colistimethate sodium (CMS). However, in the currently reported studies, most of the clinical studies on colistin for parenteral use are referred to as CMS....
Autores principales: | Yu, Xu-ben, Zhang, Xiao-Shan, Wang, Ye-Xuan, Wang, Yu-Zhen, Zhou, Hong-Min, Xu, Fang-Min, Yu, Jun-Hui, Zhang, Li-Wen, Dai, Ying, Zhou, Zi-Ye, Zhang, Chun-Hong, Lin, Guan-Yang, Pan, Jing-Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243584/ https://www.ncbi.nlm.nih.gov/pubmed/35784679 http://dx.doi.org/10.3389/fphar.2022.915958 |
Ejemplares similares
-
Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022) -
Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients
por: Wu, Fan, et al.
Publicado: (2022) -
Commentary: Population pharmacokinetics of colistin sulfate in critically ill patients: Exposure and clinical efficacy
por: Chen, Huadong, et al.
Publicado: (2022) -
Model Based Identification of Linezolid Exposure–toxicity Thresholds in Hospitalized Patients
por: Fang, Jie, et al.
Publicado: (2021) -
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)